# Estimation of the Effective Dose (ED) 95 of Intrathecal Hyperbaric Prilocaine 2% for Scheduled Cesarean Delivery.

> **NCT03607916** · PHASE2 · COMPLETED · sponsor: **Centre Hospitalier Universitaire Saint Pierre** · enrollment: 40 (actual)

## Conditions studied

- Pregnant Women

## Interventions

- **DRUG:** Hyperbaric prilocaine 2%
- **DRUG:** Hyperbaric prilocaine 2%
- **DRUG:** Morphine

## Key facts

- **NCT ID:** NCT03607916
- **Lead sponsor:** Centre Hospitalier Universitaire Saint Pierre
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02
- **Primary completion:** 2014-08
- **Final completion:** 2014-08
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2018-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03607916

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03607916, "Estimation of the Effective Dose (ED) 95 of Intrathecal Hyperbaric Prilocaine 2% for Scheduled Cesarean Delivery.". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03607916. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*